FUTURE-GB: functional and ultrasound-guided resection of glioblastoma – a two-stage randomised control trial
<p><strong>Introduction</strong> Surgery remains the mainstay for treatment of primary glioblastoma, followed by radiotherapy and chemotherapy. Current standard of care during surgery involves the intraoperative use of image-guidance and 5-aminolevulinic acid (5-ALA). There are mul...
Main Authors: | Plaha, P, Camp, S, Cook, J, McCulloch, P, Voets, N, Ma, R, Taphoorn, MJB, Dirven, L, Grech-Sollars, M, Watts, C, Bulbeck, H, Jenkinson, MD, Williams, M, Lim, A, Dixon, L, Price, SJ, Ashkan, K, Apostolopoulos, V, Barber, VS, Taylor, A, Nandi, D |
---|---|
Other Authors: | FUTURE-GB collaborators |
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2022
|
Similar Items
-
Multiple surgical resections for progressive IDH wildtype glioblastoma—is it beneficial?
by: Honeyman, SI, et al.
Published: (2024) -
Functionally guided supramaximal resection of IDH-Wildtype glioblasomas and the effect on progression free survival
by: Livermore, LJ, et al.
Published: (2018) -
Rapid development of glioblastoma at the site of atypical meningioma resection.
by: Pereira, E, et al.
Published: (2010) -
Minimally Invasive Endoscopic Resection of Intraparenchymal Brain Tumors.
by: Plaha, P, et al.
Published: (2014) -
Minimally invasive endoscopic resection of intraparenchymal brain tumors
by: Plaha, P, et al.
Published: (2014)